| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0849 |
| Trial ID | ChiCTR2000029893 |
| Disease | Blood Disease |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Co-treatment | Rocotinib |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | A single-center, open, single-arm I clinical trial of rocotenib combined with murine cd19-car T cells in the treatment of refractory/recurrent acute b-lymphoid leukemia |
| Year | 2020 |
| Country | China |
| Company sponsor | Beijing Boren Hospital |
| Cohort 1 | |||||||
|
|||||||